Skip Navigation

Diversion Quarterly Q3 2021

Diversion Quarterly Q3 2021

Kit Check is sharing data from its Bluesight™ for Controlled Substances platform on a quarterly basis to provide insight into the types of diversions and investigations that may be occurring in hospital pharmacies. The following information is as of September 30th, 2021. Data was pulled from health systems across the United States.

Key Takeaways

The opioid epidemic has not disappeared amidst the other crisis hospitals are currently faced with, in fact, it remains as prevalent as ever.

• Fentanyl is consistently the drug most likely to be diverted.

• Many hospital employees categorized as either orange or red move onto other facilities before investigations are closed or confirmed. It is crucial that hospitals leverage technology such as Bluesight for Controlled Substances to facilitate these investigations in a timely manner to ensure all potential diverters are identified.

• Unsupervised machine learning technology allows for non-biased investigations to occur based strictly on facts and not on emotion.

Download the latest information about our suite of medication intelligence products by using the button below.

Want to read the rest?